Here are five insights:
1. After a seven-day trial and five hours of deliberation, a Wisconsin jury found DePuy companies willfully infringed Acantha’s patent. The jury delivered the unanimous verdict Aug. 21.
2. In a 2015 lawsuit, Acantha accused DePuy Synthes of infringing on Acantha’s patent for an orthopedic implant assembly designed to join bone segments.
3. During the trial, the plaintiffs said patent co-inventor David Talaber informed DePuy Synthes’ predecessors about the patent both in writing and by phone.
4. The other co-inventor James Lloyd, MD, reportedly explained how the patent could alleviate DePuy’s implant device problems during a later visit to DePuy’s headquarters
5. The DePuy companies did not license the patent. Acantha claimed DePuy Synthes then infringed the patent in the Zero-P VA System and Vectra, Vectra-T and Vectra-One products, as well as other spine implant devices.
More articles on supply chain:
ASC supply chain tip of the day: Utilize automation
Steadman Clinic, Vail-Summit Orthopaedics propose 80-100K-sq-ft. surgery center
3 ways ASCs can avoid infection control lapses
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
